Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature

被引:27
作者
Brunner, F [1 ]
Wölkart, G [1 ]
机构
[1] Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, A-8010 Graz, Austria
关键词
blood pressure; coronary circulation; K-ATP channel; natriuretic peptide; nitric oxide; endothelial function; endothelial receptors;
D O I
10.1016/S0008-6363(01)00283-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Recent evidence suggests a possible role for nitric oxide (NO) in atrial natriuretic peptide-induced blood pressure effects. We tested the hypothesis that C-type natriuretic peptide (CNP)-mediated relaxation of the rat coronary circulation involves NO and activation of soluble guanylyl cyclase. Methods: Rat hearts (n=6 per group) were perfused in vitro at constant flow and the effect of CNP (0.1-3 mu mol/l) on coronary perfusion pressure (a measure of vascular tone) and release of guanosine 3 ' ,5 ' -cyclic monophosphate (cGMP) was determined in absence and presence of the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NNA; 0.2 mmol/l) or the natriuretic peptide receptor antagonist HS-142-1 (50 mug/ml). The involvement of Ca2+-gated and ATP-dependent K+ channels in CNP-induced relaxation was tested with iberiotoxin (30 nmol/l) and glibenclamide (1 mu mol/l), respectively. Rings of rat aorta (n=12) were tested using the organ bath set-up. Results: CNP reduced perfusion pressure from 134 +/-2 mmg (baseline) to 71 +/-1 mmHg (-48%) and this effect was significantly attenuated by L-NNA (-37%) or HS-142-1 (-19%). In presence of glibenclamide, CNP reduced perfusion pressure to 92 +/-2 mmHg (-32%), in presence of iberiotoxin to 93 +/-1 mmHg (-30% and in their combined presence to 102 +/-2 mmHg (-23%) (P <0.05 vs. corresponding control). Basal release of cGMP was increased up to 4-fold by CNP and this increase was reduced (-50%) in presence Of L-NNA or HS-142-1 (-68%). By contrast, relaxation of rat aortic rings mounted in organ baths was insensitive to inhibition by L-NNA. Conclusion: Relaxation of the coronary resistance vessels of the rat by CNP is partly mediated by the NO-cGMP pathway. These novel data support the existence of an endogenous link between soluble and particulate guanylyl cyclases in the control of natriuretic peptide-mediated coronary resistance vessel function. (C) 2001 Elsevier Science BY All rights reserved.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 39 条
[1]   Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide [J].
Amin, J ;
Carretero, OA ;
Ito, S .
HYPERTENSION, 1996, 27 (03) :684-687
[2]   Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries [J].
Barton, M ;
Bény, JL ;
d'Uscio, LV ;
Wyss, T ;
Noll, G ;
Lüscher, TF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (03) :377-383
[3]   Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart [J].
Brunner, F ;
Leonhard, B ;
Kukovetz, WR ;
Mayer, B .
CARDIOVASCULAR RESEARCH, 1997, 36 (01) :60-66
[4]   Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation [J].
Brunner, F ;
Wölkart, G .
MICROVASCULAR RESEARCH, 2001, 61 (01) :102-110
[5]  
Brunner F, 1996, J PHARMACOL EXP THER, V277, P48
[6]   POTASSIUM CHANNEL OPENERS AND OTHER REGULATORS OF K-ATP CHANNELS [J].
CHALLINORROGERS, JL ;
MCPHERSON, GA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (08) :583-597
[7]   A MEMBRANE FORM OF GUANYLATE-CYCLASE IS AN ATRIAL NATRIURETIC PEPTIDE RECEPTOR [J].
CHINKERS, M ;
GARBERS, DL ;
CHANG, MS ;
LOWE, DG ;
CHIN, HM ;
GOEDDEL, DV ;
SCHULZ, S .
NATURE, 1989, 338 (6210) :78-83
[8]   C-TYPE NATRIURETIC PEPTIDE - A SELECTIVE CARDIOVASCULAR PEPTIDE [J].
CLAVELL, AL ;
STINGO, AJ ;
WEI, CM ;
HEUBLEIN, DM ;
BURNETT, JC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :R290-R295
[9]   Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats [J].
Costa, MD ;
Bosc, LVG ;
Majowicz, MP ;
Vidal, NA ;
Balaszczuk, AM ;
Arranz, CT .
HYPERTENSION, 2000, 35 (05) :1119-1123
[10]   A DECADE OF ATRIAL-NATRIURETIC-FACTOR RESEARCH [J].
DEBOLD, AJ ;
KLIROSKIDEBOLD, ML ;
BOER, PH ;
DUBE, G ;
MANGAT, H ;
JOHNSON, F .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1991, 69 (10) :1480-1485